Applications: |
WB |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
MYLK2 Positive Control for STJ501837 is synthetically produced from the sequence and is suitable for use in western blot applications. |
Formulation: |
Provided as 100 uL ready-to-use, in SDS-PAGE sample buffer (Laemelli's buffer) containing Tris, pH 6.8, 1 % SDS, Glycerol and Bromophenolblue blue as tracking dye. The sample is reduced by adding 2% beta mercaptoethanol. The protein concentration is |
Dilution Range: |
WB: 1:2, 500-1:5, 000 |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
MYLK2 |
Gene ID: |
85366 |
Uniprot ID: |
MYLK2_HUMAN |
Specificity: |
This is positive control is recommended for use in combination with MYLK2 antibody STJ501837. |
Immunogen: |
Purified Protein |
Tissue Specificity | Heart and skeletal muscles. Increased expression in the apical tissue compared to the interventricular septal tissue. |
Function | Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain. |
Peptide Name | Myosin Light Chain Kinase 2 - Skeletal/Cardiac MuscleMlck2 |
Cellular Localisation | CytoplasmColocalizes With Phosphorylated Myosin Light Chain (Rlcp) At Filaments Of The Myofibrils |
Alternative Peptide Names | Myosin Light Chain Kinase 2 - Skeletal/Cardiac Muscle proteinMlck2 proteinMYLK2 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance